Global Chronic Idiopathic Constipation Drug Market Forecast 2017-2025

Published: September 2017
No. of Pages: 122
Single User License: US $ 2500
Corporate User License: US $ 4500

Key Findings
Global Chronic Idiopathic Constipation drug market is estimated to grow at a CAGR of 8.37% during the forecast period of 2017-2025. The important drivers propelling the market growth are the modern dietary habits, rising elderly population and the improved and efficient drugs in the pipeline. Linaclotide is the major type of drug popular in this market.

Market Insight
The CIC drug market is segmented based on drug types and also on the basis of prescription types. The drug types include Linaclotide, Lubiprostone, and others. The prescription type segment is further divided into over the counter drugs and prescribed drugs. An increasing demand for CIC drug from the Asia-Pacific market, coupled with the high unmet needs globally is providing the market with plenty of growth opportunities.

Regional Insights
Geographically, the global CIC drug market is segmented four major regions which include North America, Asia Pacific, Europe and Rest of World. The North America is touted to account for the largest share during the forecast period on account of its developed healthcare systems and medical devices industry. Approximately 28% of the population residing there suffer from CIC. The growing government initiatives to treat and improve the healthcare segment of the society by providing latest technological and advance medical treatments are also aiding the market growth.

Competitive Insights
Advanced product launch is the key strategy adopted by the various market players of global CIC drug market. The other strategies include acquisition and mergers. For example, Roche holding Inc acquired Ariosa Diagnostics Inc, which provides non-invasive prenatal testing (NIPT) service using cell-free DNA (cf-DNA) technology. Also, Allergan announced a collaboration with the company AstraZeneca in order to develop and commercialize ATM-AVI (aztreonam and avibactam) for antibiotic-resistant gram-negative infections. The other major players in the market include Synergy Pharmaceuticals, GlaxoSmithKline, Sucampo Pharmaceuticals Inc, Pfizer, Ironwood Pharmaceuticals Inc, etc.

Published By: Inkwood Research
Product Code: Inkwood Research97

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:


  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: